Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

131.73 +0.24 (+0.18%)
Streaming Delayed Price Updated: 9:53 AM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
46 47 Next >
Looking At Abbott Laboratories's Recent Unusual Options Activity
Via Benzinga
Got $1,000? 2 Top Dividend Stocks to Buy Now
Passive income can add to your stock market winnings. 
Via The Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Via Benzinga
Why Abbott Laboratories Stock Looks Ridiculously Overpriced
Abbott's stock is trading at a huge premium, and it isn't a justifiable one for investors. 
Via The Motley Fool
Can Boston Scientific Set Another Net High?
Boston Scientific issued a stellar report and gave favorable guidance, but the stock is having difficulty moving higher and may move sideways in the near term. 
Via MarketBeat
7 Healthcare Stocks With Huge Return Potential for Long-Term Investors
These leading healthcare companies have proven that they can deliver reliable gains to their shareholders over many years and decades. 
Via InvestorPlace
Is Abbott Laboratories Stock a Buy for Dividend Investors?
This healthcare company stands out among its peers as a Dividend King. 
Via The Motley Fool
Abbott Laboratories Unusual Options Activity
Via Benzinga
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
The Fed Predicts a Recession: Should You Still Buy Stocks Now?
The Fed expects a "mild" downturn. 
Via The Motley Fool
Sleep Easy With These 2 Rock-Solid Dividend Stocks
They aren't in any danger of crimping their dividends. 
Via The Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025. 
Via The Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
The need for noninvasive healthcare technology that allows people to take ownership and gather more insight into their health became acute when COVID revealed the fragility of the hospital system.  
Via Benzinga
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
A better-than-expected first-quarter report already pushed it much higher. 
Via The Motley Fool
Check Out What Whales Are Doing With ABT
Via Benzinga
Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
Why Abbott Laboratories Shares Are Trading Higher Today?
Via Benzinga
Abbott Labs Shakes Off Covid Test Decline To Top First-Quarter Estimates
Covid tests are still expected to bring in $1.5 billion in sales this year. 
Via Investor's Business Daily
Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review
The major indexes saw modest declines, holding in a range. 
Via Investor's Business Daily
Healthcare Sector Update: MedTech Trending Up
Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market. 
Via Talk Markets
Abbott Laboratories To Rally 17%? Here Are 10 Other Analyst Forecasts For Thursday
Morgan Stanley cut the price target for Charter Communications, Inc. (NASDAQ: CHTR) from $460 to $420. Morgan Stanley analyst Benjamin Swinburne maintained an Equal-Weight rating. Charter... 
Via Benzinga
CBOE Volatility Index Drops To Lowest Level Since November 2021; S&P 500 Ends Almost Flat
The S&P 500 closed almost flat on Wednesday following the release of corporate earnings. 
Via Benzinga
Tesla, Rivian, IBM, Zions, Lam Research: Why These Five Stocks Are Drawing Investors' Attention Today
Via Benzinga
Why Medtronic Stock Soared More Than 4% Higher Today
The veteran device maker did well on a very good day for stocks in its industry. 
Via The Motley Fool
Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,... 
Via Benzinga
Abbott's Q1 Earnings Beat Estimates, Margins Down
Abbott Laboratories reported first-quarter 2023 adjusted earnings of $1.03 per share. 
Via Talk Markets
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
Diversified Abbott Laboratories Could Reverse And Move Higher
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline. 
Via MarketBeat
Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip: Today's Top Stories
Bloomberg 
Via Benzinga
2 Stocks That Could Help Make You a Millionaire by Retirement
These companies are accustomed to delivering excellent returns. 
Via The Motley Fool
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback